diquertin

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Brain Ischemia (Cerebral Ischemia) 03/01/2005 - "[Effects of acetylsalicylic acid and diquertin on platelet aggregation and hemorheological parameters in rats with cerebral ischemia]." 03/01/2003 - "On a model of chronic brain ischemia, which is accompanied by significant deterioration of the rheological properties of blood, it was shown that a therapy with a mixture of Diquertin and Ascorbic Acid decreases the expression of the high blood viscosity syndrome."
2.	Myocardial Infarction 01/01/2003 - "Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid." 01/01/2003 - "In a model of the high blood viscosity syndrome, developed after myocardial infarction in rats, it was observed that a therapy of a combination of diquertin (20 mg/kg) and ascorbic acid (50 mg/kg) for a -period of 6 days, resulted in an improvement of haemorheological indices. "
3.	Type 2 Diabetes Mellitus (MODY) 02/01/2004 - "Mechanisms underlying diquertin-mediated regulation of neutrophil function in patients with non-insulin-dependent diabetes mellitus."
4.	Diabetes Mellitus 04/01/2003 - "[Effect of diquertin on the intensity of lipid peroxidation in patients with diabetes mellitus in the treatment of nail mycosis]."

1.	Ascorbic Acid (Vitamin C)
2.	Aspirin (Acetylsalicylic Acid)

1.	Therapeutics